About Q Bio
Q Bio is a health technology company that has rebuilt the physical exam for the era of longitudinal health. Founded in 2015 and headquartered in Redwood City, California, Q Bio integrates advanced medical technology to make preventive health more comprehensive, scalable, and actionable. The company delivers the Q Exam—a comprehensive physical examination that captures whole-body MRI imaging, 120+ blood biomarkers, genetic analysis of 163 risk-relevant genes, wearable device data, and medical history in a single visit. Each exam is reviewed by a board-certified Q Bio physician in a 45-minute consultation. The company's FDA-cleared image-analysis software, Constellation, segments organs and tissues from MRI scans, quantifying key measurements for radiologist and physician review. All results are organized in the Q Bio Health Dashboard, a longitudinal clinical record that makes every future exam comparable to the member's own baseline. Rather than providing episodic snapshots like traditional annual physicals, the Q Exam establishes a comprehensive baseline that is compared year-over-year against the patient's own prior measurements. Q Bio delivers the exam directly at its Redwood City clinic and through enterprise partnerships with concierge medicine practices, executive health programs, longevity clinics, health systems, and employer programs. The platform is designed to integrate into partners' existing care models and brand experiences, with Q Bio providing the protocol, data infrastructure, and Dashboard while partners maintain the patient relationship and clinical environment.
Mission & Story
Mission
Make a comprehensive longitudinal exam — measurable, comparable, physician-reviewed — at the scale premium care providers expect.
Founding Story
Q Bio was founded to make comprehensive preventive health measurable and longitudinal — to help physicians and patients understand change in the body over time, not just at a single visit. The company was started because the annual physical was built as an episodic snapshot, not as a longitudinal record of the body over time.
Who It Serves
Milestones & Awards
Recent Milestones
Q Bio Clinic opened in Redwood City in 2020; Dashboard matured into longitudinal clinical product 2021-2023; Platform development and refinement from 2016-2019
Key Partnerships
Company Details
- Founded
- 2015
- Headquarters
- Redwood City, CA, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 60 →
23andMe
23andMe uses AI to analyze genetic data and provide personalized health summaries, risk assessments, and wellness recommendations based on genomic insights.
2bPrecise
AI-powered precision medicine platform for personalized treatment recommendations and genomic analysis.
ACT Genomics
AI-powered genomic analysis platform for precision medicine and personalized treatment recommendations.
Adaptive Biotechnologies
Adaptive Biotechnologies uses AI and machine learning to decode the immune system and identify disease-specific immune signatures for diagnosis and personalized treatment.
Ambry Genetics
Ambry Genetics is a leading clinical genetic testing laboratory specializing in hereditary cancer, rare disease, cardiology, and neurology testing. The company provides advanced genetic testing solutions with paired DNA/RNA analysis and comprehensive patient support programs.
Ataraxis
Ataraxis develops AI-native precision medicine tools that predict patient outcomes and treatment response in oncology. Their flagship product, Ataraxis Breast, provides clinically validated prognostic and predictive tests for breast cancer using multi-modal AI analysis of pathology images and clinical data.
Avenda Health
Avenda Health develops Unfold AI, an FDA-cleared artificial intelligence platform that creates 3D cancer estimation maps for prostate cancer. The technology analyzes standard-of-care data (MRI, biopsy, pathology, PSA) to visualize cancer location and extent, helping physicians make more informed treatment decisions and improve patient outcomes.
Base Genomics
Base Genomics appears to be a company in the Precision Medicine & Genomics space, but the scraped website content is empty or inaccessible, preventing detailed analysis of their offerings and target market.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.